Terrin, M.; Migliorisi, G.; Dal Buono, A.; Gabbiadini, R.; Mastrorocco, E.; Quadarella, A.; Repici, A.; Santoro, A.; Armuzzi, A.
Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management. Int. J. Mol. Sci. 2023, 24, 11504.
https://doi.org/10.3390/ijms241411504
AMA Style
Terrin M, Migliorisi G, Dal Buono A, Gabbiadini R, Mastrorocco E, Quadarella A, Repici A, Santoro A, Armuzzi A.
Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management. International Journal of Molecular Sciences. 2023; 24(14):11504.
https://doi.org/10.3390/ijms241411504
Chicago/Turabian Style
Terrin, Maria, Giulia Migliorisi, Arianna Dal Buono, Roberto Gabbiadini, Elisabetta Mastrorocco, Alessandro Quadarella, Alessandro Repici, Armando Santoro, and Alessandro Armuzzi.
2023. "Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management" International Journal of Molecular Sciences 24, no. 14: 11504.
https://doi.org/10.3390/ijms241411504
APA Style
Terrin, M., Migliorisi, G., Dal Buono, A., Gabbiadini, R., Mastrorocco, E., Quadarella, A., Repici, A., Santoro, A., & Armuzzi, A.
(2023). Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management. International Journal of Molecular Sciences, 24(14), 11504.
https://doi.org/10.3390/ijms241411504